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Abstract
Background: There are three major B-cell compartments in peripheral lymphoid organs: the germinal center
(GC), the mantle zone (MNZ) and the marginal zone (MGZ). Unique sets of B-cells reside in these compartments,
and they have specific functional roles in humoral immune response. MNZ B cells are naïve cells in a quiescent
state and may participate in GC reactions upon proper stimulation. The adult splenic MGZ contains mostly
memory B cells and is also known to provide a rapid response to particulate antigens. The GC B-cells proliferate
rapidly and undergo selection and affinity maturation. The B-cell maturational process is accompanied by changes
in the expression of cell-surface and intracellular proteins and requires signals from the specialized
microenvironments.
Results: We performed laser microdissection of the three compartments for gene expression profiling by cDNA
microarray. The transcriptional program of the GC was dominated by upregulation of genes associated with
proliferation and DNA repair or recombination. The MNZ and MGZ showed increased expression of genes
promoting cellular quiescence. The three compartments also revealed distinct repertoires of apoptosis-
associated genes, chemokines and chemokine receptors. The MNZ and GC showed upregulation of CCL20 and
CCL18 respectively. The MGZ was characterized by high expression of many chemokines genes e.g. CXCL12,
CCL3, CCL14 and IFN-associated genes, consistent with its role in rapid response to infections. A stromal signature
was identified including genes associated with macrophages or with synthesis of extracellular matrix and genes
that influenced lymphocyte migration and survival. Differentially expressed genes that did not belong to the above
categories include the well characterized BCL6 and CD10 and many others whose function is not known.
Conclusions: Transcriptional profiling of B-cell compartments has identified groups of genes involved in critical
molecular and cellular events that affect proliferation, survival migration, and differentiation of the cells. The gene
expression study of normal B-cell compartments may additionally contribute to our understanding of the
molecular abnormalities of the corresponding lymphoid tumors.
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Appropriate T- and B-cell migration and timely interac-
tion with antigen presenting cells (APC) are essential for
the development of humoral immune responses [1,2].
Specialized compartments within lymphoid tissues facili-
tate these interactions [3]. Distinct populations of B-cells
reside in these microenvironments, and, upon antigen
stimulation, cells with appropriate antigen receptors dif-
ferentiate and migrate among these compartments for a
proper immunological reaction [4-7]. The initiation of a
T-dependent B-cell response results from cognate interac-
tion between a T-helper cell and a B-cell that primes the B-
cell into two developmental pathways. An extrafollicular
reaction takes place in the T zone and leads to the produc-
tion of plasma cells with unmutated immunoglobulin
(Ig) genes. The other pathway initiates a germinal center
(GC) reaction, whereby activated B lymphocytes originat-
ing from extrafollicular foci enter the GC and undergo a
stringent process of positive selection and affinity matura-
tion. The selected cells differentiate into either memory B-
cells or plasma cells with mutated Ig genes. The GC pro-
vides the important microenvironment for this crucial B-
cell maturational process [8,9].
In follicles with developing GCs, the resting B-cells that
are not the part of the GC response are pushed outward to
form the mantle zone (MNZ) or corona around the GC B-
cells. The mantle cell is a pre-GC, immunologically naïve
B-cell that is also the putative cell of origin of mantle cell
lymphoma [10]. These B-cells express unmutated immu-
noglobulin genes, sIgDhigh, CD27- [11] and are mostly
restricted to the follicular mantle zone [12]. In the human
spleen, there is a well defined zone between the follicular
B-cells and the red pulp called the marginal zone (MGZ)
containing marginal-zone macrophages, granulocytes and
dendritic cells that are specialized to capture blood-borne
antigens and present them to the resident marginal zone
B-cells [13]. Unlike primary lymphoid follicles in spleen
and lymph nodes, which contain mostly mature recircu-
lating B-cells, non-recirculating B-cells are enriched in the
splenic MGZ. These cells are specially adapted to respond
rapidly to T-independent (TI) antigens and have a lower
threshold than recirculating or immature B-cells for acti-
vation, proliferation and differentiation into antibody-
secreting cells [7]. They may therefore provide the early
rapid humoral response prior to the more refined but
delayed response from the GC reaction. Most adult
human MGZ B-cells have the IgMhigh, IgDlow and CD27+
phenotype, suggesting that this zone contains mainly
memory B-cells [14].
Many previous studies [15,16] have provided important
information concerning the biology of the GC. While
morphology and immunophenotype are useful in defin-
ing the various B-cell compartments of peripheral lym-
phoid organs, the molecular signals that affect the life
span, survival, retention, migration and functions of the
cells in these compartments have not been widely
investigated.
We used the Lymphochip cDNA microarray [17] to inves-
tigate the differences in gene expression profiles in the
three different B-cell compartments, the MNZ with mostly
naïve B-cells, the MGZ containing memory B-cells [18]
and specialized non-recirculating B-cells and the GC with
a mixture of highly proliferative centroblasts and more
differentiated and non-dividing centrocytes. For this
study, we used both tissue compartments isolated by laser
capture microdissection (LCM) and naïve and memory B-
cells isolated by fluorescence-activated cell sorting
(FACS). The microdissected samples contained the domi-
nant B-cell population in each compartment as well as
other cell populations in the physiological microenviron-
ment, whereas the FACS-sorted cells contained more uni-
form B-cell subsets. By comparing FACS-sorted cells with
the corresponding compartment from LCM, we have
identified a stromal cell gene expression signature that
may provide insight into stromal/B-cell interaction.
Results and discussion
Isolation of naïve and memory B-cells and different 
anatomic B-cell compartments
GC and MNZ could be readily dissected from tonsillar fro-
zen sections, but MGZ could only be reliably obtained
from the spleen (Figure 1). Immunostaining was not
applied on the sections to be microdissected because it
was difficult to obtain cells from sections on charged
slides and because immunostaining also led to a marked
loss of amplifiable RNA from the sections, even when a
rapid procedure was used [19]. Hence, immunostaining
was performed on a consecutive section to guide the dis-
section. Immunostaining by us and others has shown that
the MNZ contained over 90% B-cells, which are the IgD+
CD27-, similar to FACS-sorted naïve B-cells. The GC was
easily recognizable and generally contained a higher per-
centage of non B-cells, including T-cells, macrophages and
follicular dendritic cells (FDC). The MGZ was obtained
from a spleen with a morphologically clearly defined
MGZ containing mostly IgM+ CD27+ B-cells, correspond-
ing to the phenotype of FACS-sorted memory B-cells [14].
The MGZ also contained scattered T-cells and has been
shown by others to contain specialized macrophages and
fibroblasts [20,21]. The FACS-sorted populations were
over 90% pure, according to post-sort immunophenotyp-
ing (Figure 2).
Gene expression profiling analytical approach
Fifteen data sets corresponding to the five sample groups
were generated. Different hybridizations were correlated
through a correlation matrix plot, and replicatedPage 2 of 17
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0.85). The plots allowed us to check reproducibility of the
microarray assay among different samples of each tissue
(Figure 3). The number of genes showing differential
expression between two compartments and the magni-
tude of difference calculated by t-statistics were further fil-
tered by Significance Analysis of Microarrays (SAM)
approach, as described previously [22]. On the Lympho-
chip, over 20% of the genes are represented by multiple
clones, and, generally, several clones of same genes are
selected by our analytical algorithm. The differentially
expressed genes among the three compartments identified
by SAM were grouped according to their major functional
attributes and then viewed through Tree View.
Confirmation of the microarray analysis with semi-
quantitative RT-PCR and with real time quantitative PCR
The differential expression of some of the transcripts that
had no previously reported association with any of the
compartments was further validated by a semi-quantita-
tive RT-PCR. No discrepancies were found with any of the
selected genes. By PCR analysis, some of the transcripts
had almost exclusive expression in one compartment:
ARK2 in GC, CCL20 in MNZ and CMRF-35H in MGZ.
Other transcripts were expressed in all compartments with
a relatively high differential expression in one, such as SET
and FAIM in GC, Cyclin G2 in MNZ, and NM23-H1 and
CARD11 in MGZ (Figure 4).
Three different B-cell compartments isolated by LCMFigure 1
Three different B-cell compartments isolated by LCM. Frozen sections of reactive tonsils or spleens were fixed, and a 
consecutive section was immunostained for CD3 to guide the dissection. The three B-cell compartments (GC, MNZ and 
MGZ) were isolated using LCM with the Arcturus PixCell II system (Arcturus Engineering, Mountain View, CA). Cells were 
captured at the 15-µm with laser set to pulse at 60 mW for 200 ms. The GC and MNZ were clearly recognizable, and the 
MGZ was obtained from a spleen with a morphologically clearly defined MGZ. Only well-defined GC, MNZ and MGZ were 
dissected to avoid contamination.
Splenic marginal zone
Tonsil mantle zone
Tonsil germinal centerPage 3 of 17
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further validated by the SYBR® Green real-time
quantitative PCR (data not shown). The results corre-
sponded well with both microarray and semi-quantitative
RT-PCR.
Gene expression characteristics in anatomic B-cell 
compartments
Genes controlling cell proliferation and quiescence (Figure 5,6)
Comparing the gene expression profiles of LCM GC and
FACS-sorted GC B-cells [17] revealed that the GC B-cell
signature was largely represented in the microdissected
GC profile. The GC gene expression profile was domi-
nated by the increased expression of genes associated with
proliferation (e.g., CCNB1, PCNA, Ki67), kinetochore
association (e.g., CENPF, BUB1 and BUB3), functional
components of mitotic checkpoints (e.g., CENPE and
TTK) and regulators of cell-cycle related events, including
centrosome separation/segregation and cytokinesis (e.g.
KNSL5, ARK2), as expected from the known high prolifer-
ation rate of centroblasts. GC also highly expressed genes
involved in DNA repair (e.g., RAD54, BRCA2, RAD51,
ERCC5 and MSH2), as expected from the frequent physi-
ological double-strand DNA breaks associated with
somatic hypermutation and isotype switching. The GC
profile also showed increased levels of transcripts
involved in DNA replication (e.g., DNAJ, DNA2L,
DNMT1, TOP, RFC4 and RPA1) and in transcription and
translation (e.g., EIF2, TAF, TCF, UHRF1, UBD and
UBE2).
The low expression of the cyclins CCNA, CCNB1and
CCNF and of CDC2 (also known as CDK1) is consistent
with the resting state of the MNZ and MGZ B-cells. Char-
acteristically CCNA expression is very low in Go phase and
begins to increase in early G1. For the cell to enter the G2/
FACS-sorting of naïve and memory B-cells from splenocytesigure 2
FACS-sorting of naïve and memory B-cells from splenocytes. A single B-cell suspension prepared from a fresh spleen 
was isolated using the Human B-cell Isolation Kit (See methods) and subjected to 3-color cell sorting. Memory B-cells from the 
splenic B-cells were gated on the IgMhighIgDlowCD27+ fraction, while naïve B-cells were gated at IgMlowIgDhighCD27-. FACS-
sorted populations were over 90 % pure, judging from post sort immunophenotyping.
Spleen B cells
Memory B cells 
(IgMhiIgDlowCD27+)
Naive B cells 
(IgMlowIgDhiCD27-)
IgM-Cy-chrome       IgD-FITC                 CD27-PEPage 4 of 17
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transition requires CCNB1 to form a complex with CDC2
and relocate to the nucleus. This nuclear localization is
mediated by CCNF [24]. However, MNZ and MGZ B-cells
may also employ different mechanisms in maintaining
quiescence. Cyclin G2 (CCNG2) was highly expressed in
MNZ cells as compared to either GC or MGZ. The func-
tion of CCNG2 differs from the conventional cyclins in
negatively regulating the cell cycle [25]. Studies on HeLa
cells have showed that DNA damage induces the produc-
tion of cyclin G2, which then arrests the cell cycle at the
G1/S boundary, and this function is independent of p53.
Cyclin G2 can directly interact with the catalytic subunit
of protein phosphatase 2A (PP2A) and prevent cell cycle
progression. The low expression of CARD11 in MNZ may
also be part of the program in maintaining the quiescent
state. CARD11 has been shown to be critical for immune
receptor signaling of both T and B-cells through the
Correlation Coefficient MappingFigure 3
Correlation Coefficient Mapping. Reproducibility of the different hybridization experiments was checked through correla-
tion coefficient mapping programmed in MATLAB. High correlation is seen among samples from same compartment or FACS-
sorted population.
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Confirmation of the Microarray analysis by semi quantitative RT-PCR. aRNA amplified from GC, MNZ and MGZ -
cells was reversely transcribed and amplified by PCR. The human HPRT gene was used as the comparative standard. Five fold 
serially dilutions (4 dilutions) of each cDNA amplified with gene specific primers and analyzed by electrophoresis in 2% agarose 
gel. The transcripts had either an almost exclusive expression in one compartment (ARK2 in GC, CCL20 in MNZ and CMRF-
35H in MGZ), or they were expressed in all compartments with a significant differential expression in one – for example, SET 
and FAIM in GC, Cyclin G2 in MNZ and NM23-H1, CARD11 and GAS2 in MGZ.
GC MNZ    MGZ             N
Size (bp)
108
108
115
131
104
153
110
123
117
128
112
113
124
191
HPRT
SET
FAIM
ARK2
CIITA-8
Cyclin G2
ID3
CCL20
CCL3
SODD
CMRF-35H
NM23-H1
CARD11
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Cell proliferation and quiescence. Differential gene expression among B-cell compartments. Genes identified in SAM anal-
yses were merged according to functional or operational categories and visualized in Tree View. Color changes within a row 
indicate expression levels relative to the median of the sample population. Only transcripts differing 2-fold or more in their 
magnitude than the median or mean of the other two compartments are shown.Page 7 of 17
(page number not for citation purposes)
BMC Immunology 2004, 5:20 http://www.biomedcentral.com/1471-2172/5/20activation of JNK and NF-κB [26]. The increased transcrip-
tional level of CD72 may be involved in maintaining the
quiescent state in MNZ B-cells. CD72 contains an
immunoreceptor tyrosine-based inhibitory motif (ITIM)
in its cytoplasmic domain and functions as a negative reg-
ulator of B-cell signaling [27]. Interestingly, many genes
associated with proliferation were expressed at even lower
levels in MGZ than in MNZ cells. These cells highly
expressed growth inhibitory genes such as CMRF-35H
[28], CBL-B [29], and GAS2 [30], which may contribute to
the quiescent state in MGZ B-cells.
Apoptosis (Figure 7A)
The markedly decreased BCL2 expression in GC B-cells
makes them vulnerable to undergo apoptosis unless res-
cued by survival signals [31]. An increase in the expression
of proapoptotic genes e.g. BIK, FASL and PDCD8 (AIF)
suggests a further increase in susceptibility to apoptosis in
the GC. However, FAIM is overexpressed in the GC and
may represent a protective mechanism in GC B-cells that
have appropriate BCR signaling and CD40L stimulation
with resultant upregulation of FAIM and increased resist-
ance to FASL-mediated apoptosis [32]. Presumably, GC B-
cells with sIg having poor antigen affinity will be ineffec-
tive in activating FAIM. In addition, a TNF receptor family
member (TNFRSF17/BCMA) which promotes the B-cell
survival [33] showed increased transcription in the GC.
Programmed Cell Death 4 (PDCD4), which functions
mainly as an inhibitor of translation by inhibiting the
activity of eIF4A helicase, which helps to unwind the 5'
end of mRNAs, was markedly repressed in the GC B-cells
[34]. This suggests that PDCD4 repression facilitates the
rapid proliferation of centroblasts, which requires a high
rate of protein synthesis. Both MNZ and MGZ had higher
expression of BCL2, but have different profiles of other
apoptosis/survival genes that may represent specific adap-
tation of these cells to their unique physiological states
and microenvironment. The expression of BNIP3, encod-
ing a proapoptotic protein of the BCL2 family[35], is
markedly down regulated in MGZ cells, perhaps provid-
ing additional protection against apoptosis in memory B-
cells. On the other hand, TCL1 was upregulated in MNZ
only and may have an antiapoptotic role in that
population.
There was increased expression of Suppressor of Death
Domains (SODD) in MGZ cells, suggesting a complex reg-
ulation of signaling through the TNFR superfamily.
SODD is associated with TNFR1 in vivo, maintaining the
receptor in an inactive monomeric state. The release of
SODD from TNFR1 permits the recruitment of proteins
such as TRADD and TRAF2 to the activated TNFR1 signal-
ing complex [36]. It has been demonstrated that TNF-
induced activation of NF-κB is accelerated in SODD-defi-
cient cells. The high expression of SODD may be a major
mechanism to dampen TNFR1 signaling in MGZ B-cells in
the resting state. The higher expression of CARD11 in
MGZ may have a pro-survival function, but it may also
have a role in MGZ organization. It has been shown that
loss of CARD11 in mice resulted in the complete loss of
CD5+ peritoneal cells and reduced number of IgD high IgM
low mature splenic B-cells, indicating its role in B-cell
development [37]. Two closely related genes, NM23-H1
and NM23-H2, which share an amino acid identity of
88%, were highly expressed in MGZ. NM23 H1 is a
granzyme A-activated DNase (GAAD) that is inhibited by
SET [38]. The high expression of NM23-H1 and the low
expression of its inhibitor SET was opposite in their
expression profile in the GC, suggesting that this expres-
sion may influence apoptosis in opposite directions in
these two B-cell compartments.
Chemokines, cytokines and their receptors (Figure 7B)
Chemokines attract primary B-cells and play an important
role in the homing and localization of B-cell subsets at dif-
ferent stages of antigen-independent and dependent reac-
tion [39]. Our microarray data revealed that CCL18,
encoding a chemokine secreted by immature dendritic
cells (DC), is specifically upregulated in the GC compart-
ment. Our finding was supported by a recent report show-
ing that CCL18 is produced by GC DC and can attract
MNZ B-cells towards GC [40]. The higher expression of
CCL18 may be especially important during the onset of a
GC reaction, the time point to recruit antigen primed pre-
GC B-cells, which then interact with GC DC to initiate and
maintain the GC reaction. The GC compartment showed
increased expression of CXCL10 (IP-10). which has pleio-
tropic effects, including stimulation of monocytes and T
cell migration [41].
The GC also showed increased transcriptional level of
genes that may suppress or control inflammatory
responses; e.g., SOCS1 limits cellular response to IFNγ, IL-
2 and IL-6[42,43]. Macrophage inhibiting cytokine 1
(MIC1, also known as PLAB) [44], is only expressed by
activated macrophages, but not by resting macrophages.
Its higher expression in the GC may reflect the presence of
moderate numbers of macrophages and its possible role
in suppressing the inflammatory response in the GC.
Increased expression of the chemokine CCL20 was
observed in MNZ cells. Human naïve and memory B-cells
express the cognate receptor for CCL20, CC-chemokine
receptor 6 (CCR6) [45]. The high expression of CCL20
may play a vital role in naïve B-cell migration and locali-
zation in the MNZ. The chemokine gene CXCL12 (also
know as stromal cell-derived factor 1, SDF1) is highly
expressed in MGZ cells. The receptor for CXCL12 is
CXCR4, which is present on CD34+ cells, myeloid cells,
CD4+ T cells, B-cells, epithelial cells, endothelial cells, andPage 8 of 17
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CXCL12, which is involved in the emigration of hemat-
opoietic precursors to the marrow during embryogenesis
[46]. In peripheral lymphoid organs CXCL12 may be
involved in the migration of B-cells and possibly other
cells, such as T cells and plasma cells, to the MGZ. CCL14
(also known as HCC1) and CCL3 (also known as MIP-Iα)
were more highly expressed in the MGZ. CCL14 can acti-
vate human monocytes via receptors that also recognize
CCL3 [47]. CCL3 is a proinflammatory cytokine impor-
tant in the clearance of viral infections and the stimula-
tion of the innate immune response [48]. Thus, the
expression of this gene may be important in innate immu-
nity in the MGZ of the spleen. CXCL13 and CCL5 were
upregulated in both microdissected MGZ and MNZ com-
pared with the FACS-sorted B-cell populations. Previous
studies have established an important role for CXCL13
(BLC) in the development of Peyer's patches (PP) and
many peripheral lymph nodes. It also controls B-cell
migration and thus the organization of B-cell areas [49].
CCL5 (RANTES), a stromal related chemokine, elaborated
by activated T, NK and macrophages has been shown to
interact with CD44 to activate the MAPK pathway [50]. It
is possible that CCL5, under appropriate conditions, con-
tributes to cellular activation that may be particularly rel-
evant to MGZ B-cells, in which rapid response on
recognition of antigen stress signal is important.
A number of IFN-induced genes (AIM2, IFNGR1, and
IFNAR -1 and -2) were also preferentially expressed and
may reflect the unique function of the MGZ to provide the
first rapid response to particulate or T cell-independent
DNA repair, replication and protein synthesisFigure 6
DNA repair, replication and protein synthesis. Page 9 of 17
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(A) Apoptosis and cell survival and (B) Cytokines and chemokines and their receptors. 
(A)
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many members of G protein pathways consistent with
more active chemotaxis, cell motility and secretory func-
tions. In addition, MGZ cells showed higher expression of
IL-7Rα, consistent with the role of the IL-7R in MGZ
organization [51]. Aside from its role in B-cell differentia-
tion and proliferation IL-7Rα expression is also required
for the recruitment of precursor cells to develop in sec-
ondary lymphoid organs and for the proper structural
organization of these organs [52].
Extracellular matrix and stromal signature (Figure 8)
Cells function within the context of a three-dimensional
(3D) extracellular matrix (ECM) that participates in regu-
lating cellular motility, proliferation and survival. In the
GC, COL9A3, which encodes collagen IX [53], and
COL2A1, which encodes collagen XI [54], were uniquely
overexpressed. In the marginal zone COL14A1, COL16A1,
COL3A1 and COL6A3 were expressed at higher level,
which suggests a role for these genes in the synthesis of
specific extracellular matrix. There was also a marked
overexpression of macrophage metalloelastase 12 (MMP12),
encoding a metalloproteinase that preferentially degrades
elastin and takes part in the remodeling of extracellular
Stromal signatureFigure 8
Stromal signature. 
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MNZ.
Microdissected compartments contained a minor compo-
nent of stromal T cells, macrophages, dendritic cells and
fibroblasts whereas FACS-sorted cells from lymphoid
tissues comprise almost exclusively B-cells. Thus, an
insight into the gene expression profile of the stromal ele-
ments can be obtained by comparing the expression pro-
file of FACS-sorted and microdissected cells. We found a
set of genes that likely represent the stromal signature.
Osteonectin (SPARC), upregulated in LCM samples,
encodes a matrix-associated protein that elicits changes in
cell shape, inhibits cell-cycle progression, and influences
the synthesis of extracellular matrix [55]. It regulates
endothelial barrier function through F-actin-dependent
changes in cell shape [56]. Two members of the Maf fam-
ily (MafB, and c-Maf) were also part of the stromal signa-
ture. The Maf family of genes encode bZip nuclear
transcription factors and play an important role in mor-
phogenesis and cellular differentiation [57]. These genes
are expressed in a variety of organs, including the spleen,
in agreement with our finding. The MGZ expressed ele-
vated levels of ICAM1 and VCAM1. MGZ B cells express
the integrin LFA1 which binds to its ligands ICAM1 and
VCAM1, and this interaction may control the localization
of these B cells [58] in this compartment. Our results also
showed elevated expression of VCAM1, ITGAL (LFA-1)
and ITGA6 in the MNZ, suggesting a role for these adhe-
sion molecules in mantle cell localization as well. The
kruppel-like transcription factor BCL11a (also called
Evi9), which is essential for normal B-cell lymphopoiesis,
was upregulated in LCM cells only. Interestingly, bone
marrow from BCL11a-/- mouse can induce thymic lym-
phoma in wild type mice. Thus, the increased expression
of BCL11a in the MNZ and MGZ may be physiologically
relevant to the function of lymphocytes in these regions
[59].
Other differentially expressed genes (Figure 9)
Many genes know to be specifically expressed in GC B-
cells are found to be upregulated: e. g., BCL6, CD10,
GCET1, GCET2, JAW1 and CD38. A number of genes were
clearly upregulated in the MNZ or MGZ but their func-
tional significance is largely unknown. Some of these
would be interesting targets for further investigation.
Among the genes encoding surface molecules, CD59 was
highly expressed in the GC. CD59 antigen is a small pro-
tein that inhibits complement-mediated pore formation
or lysis by preventing the formation of membrane-embed-
ded C9 multimers [60]. It is likely that the over expression
of CD59 in GC can prevent complement-mediated dam-
age to FDCs with entrapped immune complex. CD10 and
CD38 are well established markers of GC B-cell and over
expression of the corresponding mRNA in the GC is
expected [61-63]. Notably, CIITA was markedly down
regulated in GC cells, associated with a general low
expression of MHC transcripts.
Conclusions
The gene expression profiles of the three B-cell compart-
ments reflect distinctive functional attributes of the resi-
dent B-cell populations. They also showed different
molecular microenvironments that allow the different B-
cell populations to differentiate and function properly.
GC B-cells have a high proliferation gene signature,
whereas MNZ and MGZ cells are characterized by signals
that help to maintain the quiescent state. Genes involved
in the apoptosis pathway are differentially expressed in
the three B-cell compartments, reflecting different adapta-
tions for survival in different B-cell populations. Expres-
sion of different chemokines, their receptors, and stromal
molecules have been detected. Many of these have been
implicated in the establishment of the normal lymphoid
architecture in peripheral lymphoid organs and in attract-
ing distinct immune-cell populations to specific lym-
phoid areas. The expression of unique sets of genes may
also reflect the functional adaptation of cells in a specific
location, such as genes involved in DNA repair in the GC
and genes that are active in innate immune response to
infection in the MGZ. Gene expression profiling of B-cell
compartments has allowed us to obtain a global survey of
the molecular signals that are functionally important in B-
cell subpopulations as well as the respective microenvi-
ronments. One of the major challenges is to delineate the
functions of the uncharacterized genes that are unique to
each of the compartments. Another challenge is to exploit
these normal transcriptional profiles to further our under-
standing of the normal immune response and the
derangements resulting in the corresponding lymphoid
tumors.
Methods
Laser capture microdissection (LCM)
Tissue blocks of tonsils and spleens were snap frozen in
O.C.T immediately after surgery. Four micrometer thick
frozen sections of reactive tonsils or spleens on plain glass
slides were fixed with 70% ethanol for 30 seconds, rinsed
in DEPC water and stained with hematoxylin for 30 sec-
onds, followed by another water rinse. The sections were
then dehydrated with 70%, 95% and 100% ethanol for 10
seconds each. Finally, the slides were passed through
xylene twice, each for 30 seconds. A consecutive section
was immunostained for CD3 to guide the dissection. The
three B-cell compartments (GC, MNZ and MGZ) were iso-
lated using LCM with the Arcturus PixCell II system (Arc-
turus Engineering, Mountain View, CA). To avoid
contamination, only well-defined GC, MNZ and MGZ
were dissected. Cells were captured at the 15-µm laser set-
ting on CapSure LCM Caps (Arcturus). The laser was set toPage 12 of 17
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Board of the University of Nebraska approved the usage of
tissues for this study.
Cell preparation and FACS sorting
Tissue from fresh spleens or tonsils was cut into small
pieces in cold RPMI-1640, and cells released by grinding
with a glass tissue homogenizer. The crude cell suspension
was passed through a nylon mesh (Spectrum Laborato-
ries, Inc) to generate a single-cell suspension. B-cells were
firstly isolated using the Human B-cell Isolation Kit (a
cocktail of hapten-modified antibodies to CD2, IgE, CD4,
CD11b, CD16 and CD36) and the Midi Macs system
(Miltenyi Biotec, Auburn, CA). The highly enriched B-cell
population (negative fraction) was subjected to 3-color
cell sorting. Briefly, 1 × 107 B-cells were stained with IgM-
Cy-chrome, IgD-FITC and CD27-PE (BD Pharmingen,
SanDiego, CA) at 4°C for 30 min. MGZ B-cells were iso-
lated from the splenic B-cells gated on the
IgMhighIgDlowCD27+ fraction, whereas MNZ B-cells were
selected based on IgMlowIgDhighCD27- using the BD FAC-
SVantage™ SE high-speed cell sorter (Becton-Dickinson,
SanJose, CA)
RNA extraction and T7 RNA amplification
Total RNA was extracted from each sample of microdis-
sected cells with Trizol™ (Gibco BRL, Carlsbad, CA) and
further purified with the RNeasy Mini Kit (Qiagen, Valen-
cia, CA). RNA amplification was performed using a mod-
ified Eberwine protocol [64]. Briefly, first-strand cDNA
was synthesized by reverse transcription using oligo
dT(25)-T7 anchoring primer and superscript II at 42°C for
1 hour. Second-strand synthesis was performed with 40
units E. coli DNA polymerase I, 2 units RNase H, 10 units
E. coli DNA ligase (Life Technologies, Carlsbad, CA) in
150 µl volume. Antisense RNA (aRNA) was generated by
in vitro transcription (IVT) using the Ampliscribe™ High
yield Transcription Kit (Epicentre Technologies, Madison,
WI) containing 1000 units AmpliScribe T7 enzyme at
37°C for 8–12 hours, as per the manufacture's instruc-
tion. Second-round amplification and IVT were per-
formed as described previously [65]. The quality and
quantity of aRNA were monitored on agarose gel electro-
phoresis and by spectrophotometer. Typically, 30–50 µg
of aRNA were generated from each 10 ng of total RNA by
two rounds of amplification.
Gene expression profiling using the Lymphochip
Analysis of gene expression was performed using the Lym-
phochip cDNA microarray, which contained 15,132
cDNA clones representing 7399 known or uncharacter-
ized genes [66]. Labeled cDNA from each compartment
was first hybridized with a test cDNA microarray to assess
the quality and quantity of the amplified aRNA before
using them on the Lymphochip. In each experiment,
reverse transcription was carried out on 8–9 µg of aRNA,
and aminoallyl-dUTP was incorporated into the cDNA
using a dUTP: dTTP ratio of 4:1 http://cmgm.stan
ford.edu/pbrown/protocols. The aminoallyl group on the
dUTP reacts with the ester group on the cyanine dyes. Cy3
dye was used to label the standard cDNA and Cy5 dye the
test probe, and hybridization was performed as previously
described [17].
Data and statistical analysis procedure
Each tissue type was independently isolated, amplified
and profiled in three separate experiments to enhance the
reliability of the gene expression data. Images of hybrid-
ized microarrays were obtained and processed using
GenePix 4000B microarray scanner (Axon Instruments,
Union City, CA). Spots or areas of an array with obvious
blemishes were flagged and excluded from subsequent
analyses. Fluorescence ratios were normalized for each
array by applying a single scaling factor to all fluorescent
ratios from the array [17]. The correlation coefficients
among 15 hybridized cDNA microarrays were calculated
and expressed in Correlation Coefficients Mapping
(CCM), programmed in MATLAB© (Mathworks, Inc, Nat-
ick, MA), which provided an overview of the similarity of
expression profiles between multiple samples. Only genes
with at least two values out of the triplicate experiments
showing similar behavior were included for analysis. The
expression data for each gene from an individual com-
partment was median/mean centered with weighted vari-
ance across the two or three replicates showing similar
behavior. The initial data reduction was performed using
the two-tailed student t-test to compare the differences in
gene expression levels between individual compartments.
Genes differentially expressed between the two compart-
ments with a p-value of less than 0.05 were selected for
further analysis using the Significance Analysis of Micro-
arrays (SAM) approach, as described previously [22]. SAM
assigns each gene a score based on its change in average
expression between two groups, relative to the gene's
standard deviation of permutated measurements. The
scatter plots for observed relative difference vs expected
relative difference between two compartments were used
to find the potentially significant genes and plotted in the
T-distance histogram correlating with the p-values. The
genes selected from the common set of the analysis result
from both t-statistics and SAM were grouped according to
their functional characteristics after analyzing through
OMIM or Gene Ontology database (http://
www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM or
http://www.geneontology.org) and viewed by TreeView.
Semi-quantitative and real-time quantitative PCR
To confirm the differential mRNA expression of the genes
identified by the Lymphochip in different B-cell compart-
ments, a semi-quantitative RT-PCR was employed. InPage 14 of 17
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with 200 ng random primer using MMLV-RNase H-
reverse transcriptase as per the manufacturer's instructions
(Invitrogen, Carlsbad, CA). Five-fold serially diluted
cDNAs from GC, MNB and MZB were amplified with
gene-specific primers for 30 cycles with the following
cycling conditions: A denaturation step at 94°C for 2.5
minutes and then each PCR cycle at 94°C for15 sec, 52°C
for 30 sec, and 72°C for 30 sec followed by a final
extension at 72°C for 5 min. The human HPRT transcript
was used as the comparative standard. The products were
analyzed by electrophoresis in 2% agarose gel. The prim-
ers were designed to amplify the cDNA close to the 3' end
of the transcript, and all the PCR products were less than
200 bp in length.
Some of the results from the semi-quantitative RT-PCR
were also validated by the real-time quantitative PCR with
DyNAmo™ HS SYBR® Green qPCR Kit (MJ Research, Reno,
NV) on DNA Engine OPTICON2 (MJ Research, Reno, NV)
as per the manufacturer's instructions. The PCR protocol
used an initial denaturation of 95°C for 15 minutes fol-
lowed by 35 cycles (95°C for 10 sec, 52°C for 15 sec and
70°C for 20 sec). The plate was read at 70°C according to
the melting point of the amplicon. Serial dilutions of
cDNA from the lymphoid standard [67] were used to con-
struct standard curves for the target genes (FAIM, CCL3,
SODD, NM23-H1, CARD11, Cyclin G2 and CIITA-8) and
the endogenous reference genes (HPRT). For each
unknown sample, the relative amounts of target cDNAs
and reference cDNAs applied to the PCR reaction system
were calculated using linear regression analysis from the
corresponding standard curves [68]. Then the normalized
expression level of the target gene in each sample was cal-
culated by dividing the quantity of the target transcript
with the quantity of corresponding reference transcript.
The normalized values of the target transcript were used to
compare its relative expression levels in different samples.
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